Insider Selling: Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Sells $2,358,650.00 in Stock

Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction dated Friday, December 13th. The stock was sold at an average price of $67.39, for a total transaction of $2,358,650.00. Following the sale, the director now directly owns 65,100 shares in the company, valued at approximately $4,387,089. This represents a 34.97 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Nicholas Dominic Cortezi also recently made the following trade(s):

• On Monday, December 16th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The shares were sold at an average price of $66.71, for a total transaction of $2,334,850.00.

Ryan Specialty Stock Performance

NYSE:RYAN opened at $63.15 on Friday. Ryan Specialty Holdings, Inc. has a 1-year low of $41.57 and a 1-year high of $75.97. The firm has a 50 day simple moving average of $70.38 and a 200-day simple moving average of $64.70. The firm has a market cap of $16.54 billion, a PE ratio of 82.01, a P/E/G ratio of 1.52 and a beta of 0.67. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, meeting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The company had revenue of $604.69 million during the quarter, compared to the consensus estimate of $602.04 million. During the same period in the previous year, the firm posted $0.32 EPS. Ryan Specialty’s revenue was up 20.5% on a year-over-year basis. On average, equities analysts expect that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were paid a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty’s payout ratio is 57.14%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. State Street Corp grew its holdings in Ryan Specialty by 1.5% in the third quarter. State Street Corp now owns 3,273,093 shares of the company’s stock valued at $217,301,000 after purchasing an additional 49,198 shares during the period. Janus Henderson Group PLC boosted its holdings in shares of Ryan Specialty by 0.4% in the 3rd quarter. Janus Henderson Group PLC now owns 3,148,916 shares of the company’s stock valued at $209,058,000 after purchasing an additional 13,986 shares during the last quarter. Blair William & Co. IL grew its stake in shares of Ryan Specialty by 3.4% during the 2nd quarter. Blair William & Co. IL now owns 2,866,003 shares of the company’s stock valued at $165,970,000 after buying an additional 94,663 shares during the period. Barclays PLC increased its holdings in shares of Ryan Specialty by 1.1% during the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock worth $108,994,000 after buying an additional 17,267 shares during the last quarter. Finally, Eagle Asset Management Inc. raised its position in shares of Ryan Specialty by 32.1% in the 3rd quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock worth $98,555,000 after buying an additional 335,180 shares during the period. Institutional investors and hedge funds own 84.82% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on RYAN shares. BMO Capital Markets raised Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. Barclays lifted their price target on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. The Goldman Sachs Group increased their price objective on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. Wells Fargo & Company lifted their target price on shares of Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 10th. Finally, Bank of America increased their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Ryan Specialty presently has a consensus rating of “Hold” and an average target price of $73.50.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.